NO965516L - Sterolderivater anvendt til regulering av meiose - Google Patents

Sterolderivater anvendt til regulering av meiose

Info

Publication number
NO965516L
NO965516L NO965516A NO965516A NO965516L NO 965516 L NO965516 L NO 965516L NO 965516 A NO965516 A NO 965516A NO 965516 A NO965516 A NO 965516A NO 965516 L NO965516 L NO 965516L
Authority
NO
Norway
Prior art keywords
sterol derivatives
derivatives used
regulate meiosis
meiosis
regulate
Prior art date
Application number
NO965516A
Other languages
English (en)
Other versions
NO314534B1 (no
NO965516D0 (no
Inventor
Anne Grete Byskov
Claus Yding Andersen
Lars Nordholm
Henning Thoegersen
Ole Wassmann
Ivan Verner Diers
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO965516D0 publication Critical patent/NO965516D0/no
Publication of NO965516L publication Critical patent/NO965516L/no
Publication of NO314534B1 publication Critical patent/NO314534B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
NO19965516A 1994-06-23 1996-12-20 Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro NO314534B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (3)

Publication Number Publication Date
NO965516D0 NO965516D0 (no) 1996-12-20
NO965516L true NO965516L (no) 1997-02-21
NO314534B1 NO314534B1 (no) 2003-04-07

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965516A NO314534B1 (no) 1994-06-23 1996-12-20 Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro

Country Status (26)

Country Link
US (1) US5716777A (no)
EP (1) EP0767798B1 (no)
JP (1) JP3987105B2 (no)
KR (1) KR100408369B1 (no)
CN (1) CN1068333C (no)
AT (1) ATE248852T1 (no)
AU (1) AU694240B2 (no)
BG (1) BG101067A (no)
BR (1) BR9508074A (no)
CA (1) CA2192941C (no)
CZ (1) CZ289407B6 (no)
DE (1) DE69531682T2 (no)
DK (1) DK0767798T3 (no)
ES (1) ES2204955T3 (no)
FI (1) FI117159B (no)
HU (1) HUT76343A (no)
IL (1) IL114294A (no)
IS (1) IS4404A (no)
MX (1) MX9700174A (no)
NO (1) NO314534B1 (no)
PL (1) PL186688B1 (no)
RU (1) RU2194510C2 (no)
SI (1) SI9520077A (no)
SK (1) SK165596A3 (no)
UA (1) UA51622C2 (no)
WO (1) WO1996000235A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0813595A1 (en) * 1995-03-06 1997-12-29 Novo Nordisk A/S Stimulation of meiosis
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
AU6122696A (en) * 1995-06-23 1997-01-22 Novo Nordisk A/S Meiosis regulating compounds
ATE254628T1 (de) * 1995-06-23 2003-12-15 Novo Nordisk As Meiose regulierende verbindungen.
EP0946584B1 (en) 1996-12-20 2003-04-23 Novo Nordisk A/S Meiosis regulating compounds
AU726016B2 (en) * 1997-05-16 2000-10-26 Akzo Nobel N.V. 20-aralkyl-5alpha-pregnane derivatives
IL132799A0 (en) * 1997-06-04 2001-03-19 Akzo Nobel Nv 17Beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
ATE220686T1 (de) 1997-12-18 2002-08-15 Akzo Nobel Nv 17beta-aryl(arylmethyl)oxy(thio)alkyl- androstanderivative
JP2003522728A (ja) * 1998-05-13 2003-07-29 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
KR20010043558A (ko) * 1998-05-13 2001-05-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
KR20010043828A (ko) * 1998-05-26 2001-05-25 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 ｃＡＭＰ-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법
AU4498299A (en) * 1998-06-19 2000-01-10 Novo Nordisk A/S Meiosis regulating compounds
US6528501B1 (en) * 1998-12-11 2003-03-04 Akzo Nobel N.V. 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
WO2000036132A1 (en) * 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
KR20010101820A (ko) * 1999-02-10 2001-11-14 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 불포화 콜레스탄 유도체 및 감수분열 조절 약제 제조에있어서 그의 용도
EP1156821B1 (en) * 1999-02-24 2007-05-02 Novo Nordisk A/S Treatment of infertility
AU2794100A (en) 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
DK1163258T3 (da) * 1999-03-09 2003-03-31 Akzo Nobel Nv Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis
JP2003509365A (ja) * 1999-09-16 2003-03-11 ノボ ノルディスク アクティーゼルスカブ Ｉｖｆ用の組成物
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
AU2001263924A1 (en) * 2000-05-18 2001-11-26 Novo-Nordisk A/S Fertilization of aged oocytes
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
US9376462B2 (en) 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
ATE248852T1 (de) 2003-09-15
NO314534B1 (no) 2003-04-07
FI965144A0 (fi) 1996-12-20
US5716777A (en) 1998-02-10
HUT76343A (en) 1997-08-28
SK165596A3 (en) 1997-08-06
BR9508074A (pt) 1997-08-12
EP0767798B1 (en) 2003-09-03
IS4404A (is) 1996-12-23
HU9603584D0 (en) 1997-02-28
AU2734395A (en) 1996-01-19
CA2192941C (en) 2009-04-14
BG101067A (en) 1997-08-29
UA51622C2 (uk) 2002-12-16
NO965516D0 (no) 1996-12-20
JPH10502060A (ja) 1998-02-24
AU694240B2 (en) 1998-07-16
FI117159B (fi) 2006-07-14
KR100408369B1 (ko) 2004-04-28
EP0767798A1 (en) 1997-04-16
IL114294A0 (en) 1995-10-31
CZ289407B6 (cs) 2002-01-16
RU2194510C2 (ru) 2002-12-20
CA2192941A1 (en) 1996-01-04
PL186688B1 (pl) 2004-02-27
JP3987105B2 (ja) 2007-10-03
WO1996000235A1 (en) 1996-01-04
PL317830A1 (en) 1997-04-28
SI9520077A (sl) 1998-06-30
DE69531682D1 (de) 2003-10-09
CZ372596A3 (en) 1997-07-16
FI965144L (fi) 1997-02-20
IL114294A (en) 2002-09-12
CN1068333C (zh) 2001-07-11
DK0767798T3 (da) 2003-12-22
MX9700174A (es) 1997-04-30
CN1151164A (zh) 1997-06-04
DE69531682T2 (de) 2004-07-15
ES2204955T3 (es) 2004-05-01

Similar Documents

Publication Publication Date Title
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
IT1285770B1 (it) Composti corticoidei
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
CA2160966A1 (fr) Derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MX9700885A (es) Nuevas heteroariloxazolidinonas.
ATE231872T1 (de) Thiazolopyrimidinderivate
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
NO965444D0 (no) Triterpen-derivat samt medikamentell sammensetning omfattende dette
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
BG100248A (bg) Инхибитори на скваленсинтетаза
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ATE227122T1 (de) Stabilisierte tablettenformulierung
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
NO923266D0 (no) Heksahydrobenzo(f)quinolinoner
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat